Cefdinir 50 MG/ML Oral Suspension — RxCUI 476576
RxNorm drug concept · Semantic clinical drug
RxCUI 476576
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
38 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI476576
Official nameCefdinir 50 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascefdinir 250 MG per 5 ML Oral Suspension; cefdinir 250 MG in 5 mL Oral Suspension
FDA products mapped26
Package NDCs mapped38
Reported Medicaid activity (SDUD)1,388,034 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cefdinir: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats mild to moderate bacterial infections such as pneumonia, sinus infections, strep throat, skin infections and, in children, ear infections. It will not help colds or the f...
- No. You can take it with or without food. Try to take it at about the same times each day, and finish the full course even if you feel better.
- It can be. Aluminum or magnesium antacids and iron supplements can lower how much cefdinir your body absorbs. Take cefdinir at least 2 hours before or after them.
- I take an antacid or iron. Is that a problem?
🕸️ Concept Web — How Cefdinir 50 MG/ML Oral Suspension Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cefdinir 50 MG/ML Oral Suspension
RxCUI 476576 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cefdinir
25037IN
-
Cefdinir
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cefdinir Oral Suspension
371326SCDF -
Cefdinir Oral Liquid Product
1160601SCDG -
Cefdinir Oral Product
1160602SCDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG -
Oral Product
1151131DFG
-
Cefdinir Oral Suspension
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cefdinir 50 MG/ML
476577SCDC
-
Cefdinir 50 MG/ML
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cefdinir 50 MG/ML
SCDC · 476577 -
Cefdinir Oral Suspension
SCDF · 371326 -
Cefdinir Oral Liquid Product
SCDG · 1160601 -
Cefdinir Oral Product
SCDG · 1160602
📦 FDA Products & Package NDCs
26 products · 38 package NDCs
38 package NDCs map to RxCUI 476576 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-4136-64 | 60 mL in 1 BOTTLE (0093-4136-64) | Cefdinir | Teva Pharmaceuticals USA, Inc. | 2007-05-08 |
| 00093-4136-73 | 100 mL in 1 BOTTLE (0093-4136-73) | Cefdinir | Teva Pharmaceuticals USA, Inc. | 2007-05-08 |
| 00093-4137-64 | 60 mL in 1 BOTTLE (0093-4137-64) | Cefdinir | Teva Pharmaceuticals USA, Inc. | 2007-05-08 |
| 00093-4137-73 | 100 mL in 1 BOTTLE (0093-4137-73) | Cefdinir | Teva Pharmaceuticals USA, Inc. | 2007-05-08 |
| 50090-2735-00 | 1 BOTTLE in 1 CARTON (50090-2735-0) / 60 mL in 1 BOTTLE | Cefdinir | A-S Medication Solutions | 2016-12-29 |
| 50090-3723-00 | 100 mL in 1 BOTTLE (50090-3723-0) | Cefdinir | A-S Medication Solutions | 2018-10-25 |
| 50090-5811-00 | 60 mL in 1 BOTTLE (50090-5811-0) | cefdinir | A-S Medication Solutions | 2021-10-18 |
| 50090-6171-00 | 60 mL in 1 BOTTLE (50090-6171-0) | Cefdinir | A-S Medication Solutions | 2022-10-14 |
| 63187-0616-00 | 100 mL in 1 BOTTLE (63187-616-00) | Cefdinir | Proficient Rx LP | 2007-05-08 |
| 63187-0616-60 | 60 mL in 1 BOTTLE (63187-616-60) | Cefdinir | Proficient Rx LP | 2007-05-08 |
| 65862-0218-01 | 1 BOTTLE in 1 CARTON (65862-218-01) / 100 mL in 1 BOTTLE | Cefdinir | Aurobindo Pharma Limited | 2007-12-14 |
| 65862-0218-60 | 1 BOTTLE in 1 CARTON (65862-218-60) / 60 mL in 1 BOTTLE | Cefdinir | Aurobindo Pharma Limited | 2007-12-14 |
| 65862-0219-01 | 1 BOTTLE in 1 CARTON (65862-219-01) / 100 mL in 1 BOTTLE | Cefdinir | Aurobindo Pharma Limited | 2007-12-14 |
| 65862-0219-60 | 1 BOTTLE in 1 CARTON (65862-219-60) / 60 mL in 1 BOTTLE | Cefdinir | Aurobindo Pharma Limited | 2007-12-14 |
| 67877-0547-88 | 100 mL in 1 BOTTLE (67877-547-88) | cefdinir | Ascend Laboratories, LLC | 2021-02-20 |
| 67877-0547-98 | 60 mL in 1 BOTTLE (67877-547-98) | cefdinir | Ascend Laboratories, LLC | 2021-02-20 |
| 67877-0548-88 | 100 mL in 1 BOTTLE (67877-548-88) | cefdinir | Ascend Laboratories, LLC | 2021-02-20 |
| 67877-0548-98 | 60 mL in 1 BOTTLE (67877-548-98) | cefdinir | Ascend Laboratories, LLC | 2021-02-20 |
| 68071-3403-01 | 100 mL in 1 BOTTLE (68071-3403-1) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2023-05-16 |
| 68071-5106-06 | 60 mL in 1 BOTTLE (68071-5106-6) | Cefdinir | NuCare Pharmaceuticals,Inc. | 2019-11-07 |
| 68180-0722-04 | 60 mL in 1 BOTTLE (68180-722-04) | Cefdinir | Lupin Pharmaceuticals, Inc. | 2020-05-22 |
| 68180-0722-05 | 100 mL in 1 BOTTLE (68180-722-05) | Cefdinir | Lupin Pharmaceuticals, Inc. | 2020-05-22 |
| 68180-0723-04 | 60 mL in 1 BOTTLE (68180-723-04) | Cefdinir | Lupin Pharmaceuticals, Inc. | 2020-05-22 |
| 68180-0723-05 | 100 mL in 1 BOTTLE (68180-723-05) | Cefdinir | Lupin Pharmaceuticals, Inc. | 2020-05-22 |
| 68788-4106-01 | 100 mL in 1 BOTTLE (68788-4106-1) | Cefdinir | Preferred Pharmaceuticals Inc. | 2026-04-21 |
| 68788-8655-01 | 100 mL in 1 BOTTLE (68788-8655-1) | Cefdinir | Preferred Pharmaceuticals Inc. | 2024-05-09 |
| 71205-0380-00 | 100 mL in 1 BOTTLE (71205-380-00) | Cefdinir | Proficient Rx LP | 2021-06-03 |
| 71205-0380-60 | 60 mL in 1 BOTTLE (71205-380-60) | Cefdinir | Proficient Rx LP | 2020-01-06 |
| 71205-0405-00 | 1 BOTTLE in 1 CARTON (71205-405-00) / 100 mL in 1 BOTTLE | Cefdinir | Proficient Rx LP | 2020-02-18 |
| 71205-0405-60 | 1 BOTTLE in 1 CARTON (71205-405-60) / 60 mL in 1 BOTTLE | Cefdinir | Proficient Rx LP | 2020-05-28 |
| 72189-0043-32 | 5 mL in 1 BOTTLE (72189-043-32) | CEFDINIR | DIRECT RX | 2019-11-25 |
| 72189-0185-32 | 60 mL in 1 BOTTLE (72189-185-32) | CEFDINIR | DIRECT RX | 2021-04-12 |
| 72189-0186-32 | 60 mL in 1 BOTTLE (72189-186-32) | CEFDINIR | DIRECT RX | 2021-04-12 |
| 72189-0259-32 | 100 mL in 1 BOTTLE (72189-259-32) | CEFDINIR | DIRECT RX | 2021-09-13 |
| 76420-0327-01 | 100 mL in 1 BOTTLE (76420-327-01) | Cefdinir | Asclemed USA, Inc. | 2025-04-19 |
| 76420-0327-60 | 60 mL in 1 BOTTLE (76420-327-60) | Cefdinir | Asclemed USA, Inc. | 2025-04-19 |
| 76420-0328-01 | 100 mL in 1 BOTTLE (76420-328-01) | Cefdinir | Asclemed USA, Inc. | 2025-04-19 |
| 76420-0328-60 | 60 mL in 1 BOTTLE (76420-328-60) | Cefdinir | Asclemed USA, Inc. | 2025-04-19 |
Observed labelers:
Proficient Rx LP (6) ·
A-S Medication Solutions (4) ·
Ascend Laboratories, LLC (4) ·
Asclemed USA, Inc. (4) ·
Aurobindo Pharma Limited (4) ·
DIRECT RX (4)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.